BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Prior to FDA Vote, Advisory Committee Cites Study Bias Concerns Over Amgen (AMGN) Cancer Vaccine     4/27/2015
EXCLUSIVE: Jounce CEO Says Funding Aims for Trials Next Year, Will Hire 10     4/24/2015
Celgene (CELG) Slaps Down $450 Million Upfront for AstraZeneca PLC (AZN)'s Prized Immunotherapy Blood Cancer Drug     4/24/2015
Innate Pharma (IPH.PA ) Strikes Cancer Pact Worth $1.275 Billion With Pharma Giant AstraZeneca PLC (AZN)     4/24/2015
Pfizer (PFE)'s New Leukemia Drug Meets Hematologic Remission Endpoint in Phase III Study     4/22/2015
Novartis AG (NVS) Taps Cancer Guru to Head Boston R&D Group That Specializes in Immuno-Oncology     4/22/2015
CAR-T Cell Companies Juno Therapeutics (JUNO), Kite Pharma (KITE), and ZIOPHARM, Inc. Get Stock Jitters on Disappointing Novartis AG (NVS) Trial News     4/22/2015
Investors Suddenly Interested in Synta (SNTA) and Its Upcoming Cancer Data     4/17/2015
ThromboGenics NV (TBGNF) and VIB Form New Company to Research Roche (RHHBY)-Rejected Cancer Drug     4/16/2015
Roche (RHHBY) Says 11 Late-Stage Cancer Drugs Will Enter Trials in 2015     4/15/2015
MorphoSys AG CEO Believes Drug Isn't Dead Even After Celgene (CELG) Abandons $818 Million Pact     4/6/2015
European Regulators Postpone Bristol-Myers Squibb (BMY)’s Opdivo Decision Until April or Later, As Markets Wait Anxiously     3/31/2015
MorphoSys AG Tanks 20% on Celgene (CELG) Cancer Pact Breakup News     3/30/2015
CAR-T, Checkpoint Inhibitors and Vaccines All Key at Crucial Conference, Says Cowen and Company     3/27/2015
AstraZeneca PLC (AZN) Trudges Behind in Cancer Race Where Losing May Force a Buyout     3/20/2015
 Featured Stories
Turmeric May Help Treat Oral Cancers, Emory University Study     4/24/2015
Toxic Drug May Help Battle Colorectal Cancer, MD Anderson Cancer Center Study     4/23/2015
Warning: Too Many Dietary Supplements Ups Your Cancer Risk, University Of Colorado Cancer Center Study     4/23/2015
Chamomile Tea Linked To Lower Thyroid Cancer Risk, Oxford University Study     4/22/2015
Long Term, Regular Aspirin Use May Reduce Cancer Risk, Harvard School of Public Health Study     4/21/2015
Broccoli Sprout May Prevent Head and Neck Cancer, University of Pittsburgh Cancer Institute (UPCI) Study     4/20/2015
Soyfoods Reduce Breast Cancer Recurrence, University Medical Center Study     4/20/2015
How This Company Is Using Artificial Intelligence To Develop A Cure For Cancer     4/17/2015
Cancer Linked To Muscle-Building Supplements, Brown University Study     4/15/2015
New Evidence For How Green Tea And Apples Could Protect Health, Norwich BioScience Institutes Study     4/14/2015
Cancer Surge In China Prompts Rise Of Special Patient Hotels     4/13/2015
Does More Cancer Screening Cut Cancer Deaths?     4/8/2015
Saccharin Shows Promise As Cancer Inhibitor, University of Florida Researchers Find     4/1/2015
Is Hummus Good For You? 6 Health Issues The Superfood Dip Can Treat     3/31/2015
Fitness Level Associated With Lower Risk Of Some Cancers, Death In Men, University of Vermont Study     3/27/2015
 More News
NeoStem, Inc.'s Lead Immuno-Oncology Product Candidate, NBS20, Receives ATMP Classification From The European Medicines Agency     4/27/2015
Case Western Reserve University Release: Breakthrough Provides New Hope For More Effective Treatments For Patients With HER2+ Breast Cancer     4/24/2015
MedImmune (AZN) And Juno Therapeutics (JUNO) Announce Immuno-Oncology Clinical Trial Collaboration     4/23/2015
Biothera’s Investigational Cancer Immunotherapy Alleviates Immune Suppression By Regulatory T Cells, Enabling CD4 And CD8 T Cell Proliferation, Study Finds     4/22/2015
Verastem, Inc. (VSTM) Presents Encouraging Scientific Data On The Preferential Targeting Of Cancer Stem Cells At The 2015 AACR Annual Meeting     4/22/2015
Heat Biologics. To Present At The 2015 AACR Annual Meeting     4/22/2015
BIND Therapeutics (BIND) Presents Data Highlighting Ability Of Accurins To Control Biodistribution And Accumulate In Target Tissue At AACR Annual Meeting 2015     4/22/2015
Deciphera Pharmaceuticals Presents Data Highlighting Kinase Inhibitor Pipeline Including Proprietary And Partnered Programs At AACR 2015 Annual Meeting     4/22/2015
Strategia Therapeutics Initiates A Phase 1/2a Clinical Trial Of The Anti-Cancer Agent E6201 In Patients With Advanced Hematologic Malignancies     4/22/2015
Astellas Pharma Inc. (ALPMY) And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics     4/22/2015
Biothera’s Imprime PGG Cancer Immunotherapy Drug Candidate Shows Potential To Enhance Efficacy Of Immune Checkpoint Inhibitors     4/21/2015
Biothera’s Imprime PGG Investigational Immunotherapy Drug Modulates The Function Of Macrophages And Dendritic Cells To Drive Expansion Of Anti-Cancer T Cells     4/21/2015
New Data Demonstrate Potential Of Biothera’s Investigational Cancer Immunotherapy To Re-Orient The Tumor Microenvironment To Facilitate Greater Anti-Tumor Activity     4/21/2015
Biothera’s Investigational Cancer Immunotherapy Drug Imprime PGG Elicits Dramatic Expansion Of Cytotoxic T Cells     4/21/2015
Loxo Oncology (LOXO)'s LOXO-101 Demonstrates Encouraging Initial Results From Ongoing Phase Ia Dose Escalation Study     4/21/2015